Ron Price is Head of Commercial Operations of Accelerate Diagnostics, Inc. Currently has a direct ownership of 40,610 shares of AXDX, which is worth approximately $52,793. The most recent transaction as insider was on Apr 22, 2022, when has been sold 15,072 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $14,771. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.6K
0% 3M change
0% 12M change
Total Value Held $52,793

Ron Price Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 22 2022
SELL
Open market or private sale
$14,771 $0.98 p/Share
15,072 Reduced 27.07%
40,610 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
-
40,755 Added 42.26%
55,682 Common Stock
May 13 2021
SELL
Open market or private sale
$42,466 $6.76 p/Share
6,282 Reduced 29.62%
14,927 Common Stock
May 12 2021
BUY
Exercise of conversion of derivative security
-
19,335 Added 47.69%
21,209 Common Stock
Dec 17 2020
SELL
Open market or private sale
$5,358 $7.37 p/Share
727 Reduced 27.95%
1,874 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
-
2,601 Added 50.0%
2,601 Common Stock
RP

Ron Price

Head of Commercial Operations
Tucson, AZ

Track Institutional and Insider Activities on AXDX

Follow Accelerate Diagnostics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

News

Receive news related to Accelerate Diagnostics, Inc

Track Activities on AXDX